Europe Next-Generation Biologics Market Report 2016

Publisher Name :
Date: 22-Nov-2016
No. of pages: 104
Inquire Before Buying

Notes:

Sales, means the sales volume of Next-Generation Biologics

Revenue, means the sales value of Next-Generation Biologics

This report studies sales (consumption) of Next-Generation Biologics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Allergan

- Bayer

- Biogen Idec

- Eli Lilly

- Kyowa Hakko Kirin

- Molecular Partners

- Novo Nordisk

- Pfizer

- Roche

- Sanofi

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Next-Generation Biologics in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Antibodies

- Regenerative medicine

- Insulins

- Growth hormones

- Other

Split by application, this report focuses on sales, market share and growth rate of Next-Generation Biologics in each application, can be divided into

- Medical

- Scientific Research

- Other

Europe Next-Generation Biologics Market Report 2016

Table of Contents
Europe Next-Generation Biologics Market Report 2016
1 Next-Generation Biologics Overview
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics
1.2.1 Antibodies
1.2.2 Regenerative medicine
1.2.3 Insulins
1.2.4 Growth hormones
1.2.5 Other
1.3 Application of Next-Generation Biologics
1.3.1 Medical
1.3.2 Scientific Research
1.3.3 Other
1.4 Next-Generation Biologics Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Next-Generation Biologics (2011-2021)
1.5.1 Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
1.5.2 Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)
2 Europe Next-Generation Biologics by Manufacturers, Type and Application
2.1 Europe Next-Generation Biologics Market Competition by Manufacturers
2.1.1 Europe Next-Generation Biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Next-Generation Biologics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Next-Generation Biologics (Volume and Value) by Type
2.2.1 Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
2.2.2 Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
2.3 Europe Next-Generation Biologics (Volume and Value) by Countries
2.3.1 Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Next-Generation Biologics (Volume) by Application
3 Germany Next-Generation Biologics (Volume, Value and Sales Price)
3.1 Germany Next-Generation Biologics Sales and Value (2011-2016)
3.1.1 Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
3.1.2 Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
3.1.3 Germany Next-Generation Biologics Sales Price Trend (2011-2016)
3.2 Germany Next-Generation Biologics Sales and Market Share by Manufacturers
3.3 Germany Next-Generation Biologics Sales and Market Share by Type
3.4 Germany Next-Generation Biologics Sales and Market Share by Application
4 France Next-Generation Biologics (Volume, Value and Sales Price)
4.1 France Next-Generation Biologics Sales and Value (2011-2016)
4.1.1 France Next-Generation Biologics Sales and Growth Rate (2011-2016)
4.1.2 France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
4.1.4 France Next-Generation Biologics Sales Price Trend (2011-2016)
4.2 France Next-Generation Biologics Sales and Market Share by Manufacturers
4.3 France Next-Generation Biologics Sales and Market Share by Type
4.4 France Next-Generation Biologics Sales and Market Share by Application
5 UK Next-Generation Biologics (Volume, Value and Sales Price)
5.1 UK Next-Generation Biologics Sales and Value (2011-2016)
5.1.1 UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
5.1.2 UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
5.1.5 UK Next-Generation Biologics Sales Price Trend (2011-2016)
5.2 UK Next-Generation Biologics Sales and Market Share by Manufacturers
5.3 UK Next-Generation Biologics Sales and Market Share by Type
5.4 UK Next-Generation Biologics Sales and Market Share by Application
6 Russia Next-Generation Biologics (Volume, Value and Sales Price)
6.1 Russia Next-Generation Biologics Sales and Value (2011-2016)
6.1.1 Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
6.1.2 Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
6.1.6 Russia Next-Generation Biologics Sales Price Trend (2011-2016)
6.2 Russia Next-Generation Biologics Sales and Market Share by Manufacturers
6.3 Russia Next-Generation Biologics Sales and Market Share by Type
6.4 Russia Next-Generation Biologics Sales and Market Share by Application
7 Italy Next-Generation Biologics (Volume, Value and Sales Price)
7.1 Italy Next-Generation Biologics Sales and Value (2011-2016)
7.1.1 Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
7.1.2 Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
7.1.7 Italy Next-Generation Biologics Sales Price Trend (2011-2016)
7.2 Italy Next-Generation Biologics Sales and Market Share by Manufacturers
7.3 Italy Next-Generation Biologics Sales and Market Share by Type
7.4 Italy Next-Generation Biologics Sales and Market Share by Application
8 Spain Next-Generation Biologics (Volume, Value and Sales Price)
8.1 Spain Next-Generation Biologics Sales and Value (2011-2016)
8.1.1 Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
8.1.2 Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
8.1.8 Spain Next-Generation Biologics Sales Price Trend (2011-2016)
8.2 Spain Next-Generation Biologics Sales and Market Share by Manufacturers
8.3 Spain Next-Generation Biologics Sales and Market Share by Type
8.4 Spain Next-Generation Biologics Sales and Market Share by Application
9 Benelux Next-Generation Biologics (Volume, Value and Sales Price)
9.1 Benelux Next-Generation Biologics Sales and Value (2011-2016)
9.1.1 Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
9.1.2 Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
9.2 Benelux Next-Generation Biologics Sales and Market Share by Manufacturers
9.3 Benelux Next-Generation Biologics Sales and Market Share by Type
9.4 Benelux Next-Generation Biologics Sales and Market Share by Application
10 Europe Next-Generation Biologics Manufacturers Analysis
10.1 Allergan
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Next-Generation Biologics Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Bayer
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Next-Generation Biologics Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Biogen Idec
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Next-Generation Biologics Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Eli Lilly
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Next-Generation Biologics Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Kyowa Hakko Kirin
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Next-Generation Biologics Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Molecular Partners
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Next-Generation Biologics Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Next-Generation Biologics Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Pfizer
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Next-Generation Biologics Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Roche
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Next-Generation Biologics Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Sanofi
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Next-Generation Biologics Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Next-Generation Biologics Manufacturing Cost Analysis
11.1 Next-Generation Biologics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Next-Generation Biologics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Next-Generation Biologics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Next-Generation Biologics Market Forecast (2016-2021)
14.1 Germany Next-Generation Biologics Sales Forecast (2016-2021)
14.2 France Next-Generation Biologics Sales Forecast (2016-2021)
14.3 UK Next-Generation Biologics Sales Forecast (2016-2021)
14.4 Russia Next-Generation Biologics Sales Forecast (2016-2021)
14.5 Italy Next-Generation Biologics Sales Forecast (2016-2021)
14.6 Spain Next-Generation Biologics Sales Forecast (2016-2021)
14.7 Benelux Next-Generation Biologics Sales Forecast (2016-2021)
14.8 Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
14.9 Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Next-Generation Biologics
Table Classification of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Type in 2015
Figure Antibodies Picture
Figure Regenerative medicine Picture
Figure Insulins Picture
Figure Growth hormones Picture
Figure Other Picture
Table Application of Next-Generation Biologics
Figure Europe Sales Market Share of Next-Generation Biologics by Application in 2015
Figure Medical Examples
Figure Scientific Research Examples
Figure Other Examples
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Sales and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Table Europe Next-Generation Biologics Sales of Key Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Next-Generation Biologics Sales Share by Manufacturers
Figure 2016 Next-Generation Biologics Sales Share by Manufacturers
Table Europe Next-Generation Biologics Revenue by Manufacturers (2015 and 2016)
Table Europe Next-Generation Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table 2016 Europe Next-Generation Biologics Revenue Share by Manufacturers
Table Europe Next-Generation Biologics Sales and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Type (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Sales Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Type (2011-2016)
Figure Europe Next-Generation Biologics Revenue Growth Rate by Type (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue and Market Share by Countries (2011-2016)
Table Europe Next-Generation Biologics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Countries (2011-2016)
Table Europe Next-Generation Biologics Sales and Market Share by Application (2011-2016)
Table Europe Next-Generation Biologics Sales Share by Application (2011-2016)
Figure Sales Market Share of Next-Generation Biologics by Application (2011-2016)
Figure Germany Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Germany Next-Generation Biologics Sales Price Trend (2011-2016)
Table Germany Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Type (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Germany Next-Generation Biologics Sales by Application (2015 and 2016)
Table Germany Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure France Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure France Next-Generation Biologics Sales Price Trend (2011-2016)
Table France Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table France Next-Generation Biologics Sales by Type (2015 and 2016)
Table France Next-Generation Biologics Market Share by Type (2015 and 2016)
Table France Next-Generation Biologics Sales by Application (2015 and 2016)
Table France Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure UK Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure UK Next-Generation Biologics Sales Price Trend (2011-2016)
Table UK Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table UK Next-Generation Biologics Sales by Type (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Type (2015 and 2016)
Table UK Next-Generation Biologics Sales by Application (2015 and 2016)
Table UK Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Russia Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Russia Next-Generation Biologics Sales Price Trend (2011-2016)
Table Russia Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Type (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Russia Next-Generation Biologics Sales by Application (2015 and 2016)
Table Russia Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Italy Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Italy Next-Generation Biologics Sales Price Trend (2011-2016)
Table Italy Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Type (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Italy Next-Generation Biologics Sales by Application (2015 and 2016)
Table Italy Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Spain Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Spain Next-Generation Biologics Sales Price Trend (2011-2016)
Table Spain Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Type (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Spain Next-Generation Biologics Sales by Application (2015 and 2016)
Table Spain Next-Generation Biologics Market Share by Application (2015 and 2016)
Figure Benelux Next-Generation Biologics Sales and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate (2011-2016)
Figure Benelux Next-Generation Biologics Sales Price Trend (2011-2016)
Table Benelux Next-Generation Biologics Sales by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Manufacturers (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Type (2015 and 2016)
Table Benelux Next-Generation Biologics Sales by Application (2015 and 2016)
Table Benelux Next-Generation Biologics Market Share by Application (2015 and 2016)
Table Next-Generation Biologics Basic Information List
Table Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Next-Generation Biologics Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Next-Generation Biologics Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Next-Generation Biologics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Next-Generation Biologics Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Next-Generation Biologics Sales Market Share (2011-2016)
Table Molecular Partners Basic Information List
Table Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Molecular Partners Next-Generation Biologics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Next-Generation Biologics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Next-Generation Biologics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Next-Generation Biologics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Next-Generation Biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next-Generation Biologics
Figure Manufacturing Process Analysis of Next-Generation Biologics
Figure Next-Generation Biologics Industrial Chain Analysis
Table Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
Table Major Buyers of Next-Generation Biologics
Table Distributors/Traders List
Figure Germany Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure France Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure UK Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Type (2016-2021)
Table Europe Next-Generation Biologics Sales Forecast by Application (2016-2021)
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • United States, EU, Japan, China, India and Southeast Asia Biosimulation Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 94
    Notes: Production, means the output of Biosimulation Revenue, means the sales value of Biosimulation This report studies the global Biosimulation market, analyzes and researches the Biosimulation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Certara - Simulation Plus - Dassault Systèmes - Schr?dinger - Advanced Chemistry D......
  • United States, EU, Japan, China, India and Southeast Asia Continuous Positive Airway Pressure Therapy Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 112
    Notes: Production, means the output of Continuous Positive Airway Pressure Therapy Revenue, means the sales value of Continuous Positive Airway Pressure Therapy This report studies the global Continuous Positive Airway Pressure Therapy market, analyzes and researches the Continuous Positive Airway Pressure Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like......
  • United States, EU, Japan, China, India and Southeast Asia Outsourced Orthopedic Manufacturing Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 111
    Notes: Production, means the output of Outsourced Orthopedic Manufacturing Revenue, means the sales value of Outsourced Orthopedic Manufacturing This report studies the global Outsourced Orthopedic Manufacturing market, analyzes and researches the Outsourced Orthopedic Manufacturing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Tecomet - Orchi......
  • Global Interventional Oncology Device Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Interventional Oncology Device Revenue, means the sales value of Interventional Oncology Device This report studies sales (consumption) of Interventional Oncology Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Intranasal Corticosteroids Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Intranasal Corticosteroids Revenue, means the sales value of Intranasal Corticosteroids This report studies sales (consumption) of Intranasal Corticosteroids in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Joh......
  • Global Interventional Oncology Devices Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Interventional Oncology Devices Revenue, means the sales value of Interventional Oncology Devices This report studies sales (consumption) of Interventional Oncology Devices in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Leukotriene Receptor Antagonist Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Leukotriene Receptor Antagonist Revenue, means the sales value of Leukotriene Receptor Antagonist This report studies sales (consumption) of Leukotriene Receptor Antagonist in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi ......
  • United States Drugs for Non-small Cell Lung Cancer Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Drugs for Non-small Cell Lung Cancer Revenue, means the sales value of Drugs for Non-small Cell Lung Cancer This report studies sales (consumption) of Drugs for Non-small Cell Lung Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Oncology......
  • Global Levocetirizine Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Levocetirizine Revenue, means the sales value of Levocetirizine This report studies sales (consumption) of Levocetirizine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi - GlaxoSmithKline - ... Market Segment by Regions, this report sp......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs